| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | CANN GROUP LIMITED: Results of AGM | 1 | ASX | ||
| Di | CANN GROUP LIMITED: Executive Chairman AGM Presentation | 2 | ASX | ||
| Di | CANN GROUP LIMITED: Chair's Address to Shareholders | - | ASX | ||
| 30.10. | CANN GROUP LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | 1 | ASX | ||
| 19.10. | CANN GROUP LIMITED: Notice of Annual General Meeting/Proxy Form | 1 | ASX | ||
| 30.09. | CANN GROUP LIMITED: Appendix 4G and Corporate Governance Statement | - | ASX | ||
| 30.09. | CANN GROUP LIMITED: Annual Report to shareholders | 4 | ASX | ||
| CANN GROUP Aktie jetzt für 0€ handeln | |||||
| 31.08. | CANN GROUP LIMITED: FY26 Results | - | ASX | ||
| 31.08. | CANN GROUP LIMITED: Preliminary Final Report | - | ASX | ||
| 30.07. | CANN GROUP LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | 1 | ASX | ||
| 13.07. | CANN GROUP LIMITED: Change of Auditor | - | ASX | ||
| 07.07. | CANN GROUP LIMITED: Notification of cessation of securities - CAN | - | ASX | ||
| 03.07. | CANN GROUP LIMITED: Increase to Private Credit Loan Facility | - | ASX | ||
| 30.06. | Cann Group (ASX:CAN) kills the Obsidian note early and lifts the dilution overhang | 1 | Stocks Down Under | ||
| 30.06. | CANN GROUP LIMITED: Early Redemption of Convertible Notes | - | ASX | ||
| 29.06. | CANN GROUP LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 18.06. | CANN GROUP LIMITED: Application for quotation of securities - CAN | - | ASX | ||
| 26.05. | CANN GROUP LIMITED: Change in substantial holding | 1 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 53,36 | -2,41 % | Moderna, Bayer, Merck investieren Milliarden - doch bei Psychedelika fehlt ein entscheidendes Teil | ||
| NOVO NORDISK | 34,485 | +0,13 % | Pharma-Turnaround-Aktien im Check - Evotec, Vidac Pharma, Novo Nordisk zwischen Umbau, Studie und Prognose | Zwischen dem 4. und dem 9. November haben gleich drei Pharma- und Biotechwerte Nachrichten vorgelegt, die nach einem Wendepunkt klingen. Beim einen schrumpfte der Quartalsverlust vor Sonderposten, beim... ► Artikel lesen | |
| AURORA CANNABIS | 3,768 | -0,69 % | Das zwingt Anleger zum Handeln: Cannabisaktien am Wendepunkt: Warum Canopy, Tilray & Co. jetzt im Fokus stehen | © Foto: adobe.stock.comDie Quartalsberichte der Cannabis-Unternehmen boten Licht und Schatten - oder sollte man besser Hoffnung und Resignation sagen? Die Unterschiede hätten nicht größer sein können.... ► Artikel lesen | |
| ABBVIE | 260,20 | -0,38 % | Dividendenbekanntmachungen (16.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,63 USD EUR ABBVIE INC US00287Y1091 1,73 USD EUR AGCO CORPORATION US0010841023 0,3 USD 0... ► Artikel lesen | |
| CANOPY GROWTH | 0,400 | +1,16 % | Why Is Canopy Growth Stock Falling Friday? | ||
| TILRAY BRANDS | 1,710 | -0,58 % | Is Tilray a Buy at Its Record Low, or Is It a Value Trap? | ||
| VERTEX PHARMACEUTICALS | 468,75 | -0,26 % | Genomics Limited: Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals | Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals
The new agreement extends an existing 8-year collaboration between the companies OXFORD,... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| DERMAPHARM | 32,750 | -2,09 % | Bafin beanstandet Konzernabschlus 2025 bei Dermapharm als fehlerhaft | FRANKFURT (dpa-AFX) - Der Konzernabschluss des Arzneimittelherstellers Dermapharm für das Jahr 2025 ist fehlerhaft. Zu diesem Schluss kommt die Finanzaufsicht Bafin nach einer im Sommer eingeleiteten... ► Artikel lesen | |
| CRONOS GROUP | 2,790 | +0,14 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN.X) | Le 6 novembre/November 2026
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant to... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,566 | +3,10 % | Organigram Global Inc: Organigram has 180 days to cure Nasdaq non-compliance | ||
| GREEN THUMB INDUSTRIES | 5,150 | +2,59 % | Green Thumb Has $316 Million in Cash, and Same-Store Sales Are Growing Again. Is It the Smartest Pot Stock to Buy? | ||
| SNDL | 1,086 | +0,46 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| CRESCO LABS | 0,360 | +2,86 % | Cresco Labs Celebrates Sunnyside Prestonsburg Grand Opening, Marking Major Milestone for Kentucky Medical Cannabis | Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today announced the grand opening of Sunnyside Prestonsburg in Kentucky, the Company's 83rd dispensary nationwide.... ► Artikel lesen |